Search
for
Sort by
Research 871–900 of 1000+
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia
- Efficacy and safety of the Exfoliate-Dissolve-Repair skin care approach in the treatment of keratosis pilaris: a randomized controlled clinical trial study protocol
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Dynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- The Intervention Effect of Externally Applying or Orally Administering Bifidobacterium animalis Subsp. lactis J12 on Atopic Dermatitis Induced by 2,4-Dinitrofluorobenzene
- Scalp Microbiome Composition in Young Women: Associations with Scalp Type, Sensitivity, and Lifestyle Factors
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- The Roles of Keratinocytes in the Initiation, Progression and Maintenance of Hidradenitis Suppurativa
- Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib
- Microneedle-Based Technologies for Long-Acting Transdermal Drug Delivery in Wearable Devices
- ADVANCEMENTS IN TREATMENT STRATEGIES FOR ANDROGENETIC ALOPECIA: NOVEL THERAPIES AND FUTURE PERSPECTIVES
- Targeted Determination of Residual Sex Hormones in Cosmetics Using Magnetic Solid-Phase Extraction with Isotope-Labeled Internal Standards by UHPLC-MS/MS
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Evaluation of Anthropometric Measurements, Arterial Stiffness and ECG Parameters in Alopecia Areata Patients
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Nucleic acid-induced chemokine expression in keratinocytes: Implications for skin inflammation
- Pathogenesis of Chemical Leukoderma and Chemical‐Induced Vitiligo
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Review of Promising Off-Label Use of Deucravacitinib
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages